Actinium Pharmaceuticals, Inc. (ATNM) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on August 12, 2026, by Actinium Pharmaceuticals, Inc. The filing addresses the Company's status regarding continued listing standards on the NYSE American LLC under the symbol "ATNM."
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance and listing status rather than financial performance metrics.
Material Changes and Listing Status
- Non-Compliance Notice: On May 27, 2026, the Company received notice from NYSE American of non-compliance with Sections 1003(a)(ii) and (iii) of the NYSE American Company Guide.
- Compliance Plan Accepted: On August 12, 2026, NYSE Regulation accepted the Company's compliance plan submitted on June 18, 2026.
- Plan Period Granted: The Company was granted a plan period extending through November 27, 2027, to regain compliance.
- Trading Status: During this plan period, the Company's common stock will continue to be listed and traded on NYSE American, subject to periodic review and adherence to the compliance plan.
Outlook, Risks, and Contingencies
The Company faces the risk of delisting if it fails to regain compliance with the applicable standards by the end of the Plan Period (November 27, 2027) or fails to make progress consistent with the compliance plan. The filing includes forward-looking statements regarding the ability to regain compliance, noting that no assurance can be provided that NYSE Regulation will determine the progress to be satisfactory.
Key Facts for Investor Verification
- Verify the specific listing standards (Sections 1003(a)(ii) and (iii)) the Company failed to meet, as these are not detailed in this summary.
- Monitor the Company's progress reports during the plan period ending November 27, 2027.
- Review the press release dated August 14, 2026 (Exhibit 99.1) for additional details on the compliance initiatives.
- Check subsequent filings for any updates on the Company's financial position, as this 8-K does not contain financial data.